Survival for testicular cancer

Survival depends on many factors, so no one can tell you exactly how long you’ll live. It depends on your individual condition, type of cancer, treatment and level of fitness.

Survival for testicular cancer is very high.

Your doctor can give you more information about your own outlook (prognosis). You can also talk about this with the Cancer Research UK information nurses on freephone 0808 800 4040, from 9am to 5pm, Monday to Friday.

About these statistics

The terms 1 year survival and 5 year survival don't mean that you will only live for 1 or 5 years.

The NHS, other health organisations, and researchers collect information. They record what happens to people with cancer in the years after their diagnosis. 5 years is a common time point to measure survival. But some people live much longer than this.

5 year survival is the number of people who have not died from their cancer within 5 years after diagnosis.

Survival for all stages of testicular cancer

The outlook for testicular cancer is one of the best for all cancers.

Generally in England:

  • around 95 out of 100 men (around 95%) will survive their cancer for 1 year or more after they are diagnosed
  • around 95 out of 100 men (around 95%) will survive their cancer for 5 years or more after diagnosis
  • around 90 out of 100 men (around 90%) will survive their cancer for 10 years or more after diagnosis

Survival if the cancer has spread

Researchers and doctors use a system to try and predict your outlook. This is for testicular cancer that has spread. Your outlook might be defined as:

  • good prognosis 
  • intermediate prognosis
  • poor prognosis

Your prognosis is worked out slightly differently, depending on whether you have:

  • pure seminoma testicular cancer
  • non seminoma testicular cancer

No UK-wide survival statistics are available for testicular cancer that has spread. The survival statistics below are from a large international study.

Pure seminoma

Pure seminoma means that there are no teratoma cells in the tumour. You will have normal Alpha fetoprotein (AFP) marker levels Open a glossary item if you have pure seminoma.

There are two categories of outlook for pure seminoma testicular cancer. These are good prognosis and intermediate prognosis. No one with pure seminoma is classified as having a poor prognosis.

Good prognosis

  • 95 out of every 100 men (95%) survive for 5 years or more after they are diagnosed

Good prognosis means that the seminoma has spread only to the lymph nodes or the lungs. It has not spread anywhere else. 

Intermediate prognosis

  • almost 90 out of every 100 men (almost 90%) survive for 5 years or more after diagnosis

Intermediate prognosis means that the seminoma has spread beyond the lung or lymph nodes. It has spread to other parts of the body, such as the brain or liver. 

 

Non seminoma

There are three categories of outlook for non seminoma testicular cancer that has spread. These are good prognosis, intermediate prognosis and poor prognosis.

Good prognosis

  • around 95 out of every 100 men (around 95%) survive for 5 years or more after they are diagnosed

Good prognosis means that your primary cancer was in your testicle, or at the back of your stomach or abdomen (retroperitoneal). It may have spread to the lungs or lymph nodes but has not spread to anywhere else in your body. Your markers are only slightly above normal. 

Intermediate prognosis

  • around 90 out of every 100 men (around 90%) survive for 5 years or more after diagnosis

Intermediate prognosis is the same as a good prognosis. But your markers are moderately higher. 

Poor prognosis

  • more than 65 out of 100 men (more than 65%) will survive for 5 years or more after diagnosis

Poor prognosis means that:

  • the primary cancer is in your chest (mediastinum) or
  • the cancer has spread to somewhere in your body other than the lungs, such as the liver or brain

You may also be in this category if your marker levels are high.

What affects survival

Your outlook depends on the stage of the cancer when it was diagnosed. This means:

  • whether it has spread to lymph nodes or other parts of your body
  • the level of certain substances (tumour markers) in your blood

The type and size of your testicular cancer also affects your likely survival.

Clinical trials

Taking part in clinical trials can help to improve the outlook for people with testicular cancer.

More statistics

You can read more statistics on survival rates and other factors for testicular cancer in our Cancer Statistics section.

  • Cancer survival in England, cancers diagnosed 2016 to 2020, followed up to 2021
    NHS England

  • EAU Guidelines on Testicular Cancer

    D Nicol and others

    European Association of Urology, 2024

  • Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
    S. Gillessen and others
    Journal of Clinical Oncology (2021) May 10, Volume 39, issue 14, Pages 1563-1574

  • Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
    International Germ Cell Cancer Collaborative Group.
    J Beyer and others
    Journal of Clinical Oncology (2021)  May 10, Volume 39, issue 14, pages 1553-1562

  • Cancer survival in England: adult, stage at diagnosis and childhood - patients followed up to 2018
    Office for National Statistics

  • Collecting and keeping patient data safe
    National Disease Registration Service (NDRS)
    Accessed February 2025

Last reviewed: 
21 Feb 2025
Next review due: 
21 Feb 2028

Related links